Direct and indirect antitumor effects by human peripheral blood lymphocytes expressing both chimeric immune receptor and interleukin-2 in ovarian cancer xenograft model.
about
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyondGenetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo.Immune therapy for ovarian cancer: promise and pitfalls.
P2860
Direct and indirect antitumor effects by human peripheral blood lymphocytes expressing both chimeric immune receptor and interleukin-2 in ovarian cancer xenograft model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Direct and indirect antitumor ...... varian cancer xenograft model.
@en
Direct and indirect antitumor ...... varian cancer xenograft model.
@nl
type
label
Direct and indirect antitumor ...... varian cancer xenograft model.
@en
Direct and indirect antitumor ...... varian cancer xenograft model.
@nl
prefLabel
Direct and indirect antitumor ...... varian cancer xenograft model.
@en
Direct and indirect antitumor ...... varian cancer xenograft model.
@nl
P2093
P2860
P356
P1433
P1476
Direct and indirect antitumor ...... varian cancer xenograft model.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2010.30
P577
2010-06-18T00:00:00Z
P5875
P6179
1000282417